About the book
Recent advancement in genetic engineering technology and biotechnology have commonly introduced a new class of therapeutic drugs - biotherapeutics. Such drugs are extracted and/or produced from biological sources and sometimes also known as biological drugs. This has revolutionized modern medicine by providing medicines to treat several complicated and life-threatening diseases like malignancy, cardiovascular associated sickness, infectious illness, respiratory diseases, and chronic inflammation and so on. Biotherapeutics is a rapidly growing class of the total pharmaceutical market and represents a significant portion of recently approved new drugs. The biotherapeutics offers a few phenomenal highlights over the conventional small-molecule pharmaceuticals due to their relatively high specificity, low off-target effects, and bio-compatible metabolism, in addition to legal and logistic advantages. Biotherapeutics include a wide assortment of bioactive molecules, for example, monoclonal antibodies, gene-silencing/editing therapies, recombinant proteins, hormones, cytokines, vaccines, growth factors, tissue-engineered products, and stem cell therapies. These drugs can be modified to improve therapeutic effectiveness of the treatment. This book intends to provide the reader with a comprehensive overview of the current advancement in biotherapeutics, and its therapeutic and biomedical application as well as recent progress and challenges.